Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
361-02-007 ISMRM Abstract

Integration of Habitat Risk Score in Novel Clinical Trial for Characterization of Ultra-Early Response for Prostate Cancer

Accepted
Adrian L Breto1, Veronica Wallaengen1, Ahmad Algohary1, Noah C Lowry1, Sandra M Gaston1, Ivaylo B Mihaylov1, Alan Pollack1, Matthew C Abramowitz1, Benjamin O Spieler1, Radka Stoyanova 1
1Radiation Oncology, University of Miami, Miami, United States of America
Presenting Author: Radka Stoyanova

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Pollack, A. et al. Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy. Int J Radiat Oncol Biol Phys 107, 305-315, doi:10.1016/j.ijrobp.2020.01.052 (2020). [doi]
2. Stoyanova, R. et al. An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes. Int J Radiat Oncol Biol Phys 102, 821-829, doi:10.1016/j.ijrobp.2018.06.003 (2018). [doi]
3. Zacharaki, E. I. et al. Integration of Habitat Risk Score (HRS) in Radiotherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys, doi:10.1016/j.ijrobp.2025.09.074 (2025). [doi]

Cite this abstract